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ABSTRACT
The present study describes a protocol to generate heterogenous populations of neurotransmitter-producing neurons 
from human mesenchymal stem cells (MSCs). MSCs are bone marrow (BM)-derived cells which undergo lineage-
specific differentiation to generate bone, fat, cartilage and muscle, but are also capable of transdifferentiating into 
defined ectodermal and endodermal tissues. The purpose of this study is to evaluate the potential of MSCs as an 
alternative source of customized neurons for experimental neurobiology or other regenerative approaches. Our 
neuronal protocol utilizes freshly harvested human MSCs cultured on specific surfaces and exposed to an induction 
cocktail consisting of low serum concentration, retinoic acid (RA), growth factors and supplements. Here we report on 
the types of neurotransmitters produced by the neurons, and demonstrate that the cells are electrically responsive to 
exogenous neurotransmitter administration.
INTRODUCTION
Stem cells hold tremendous potential in advancing the 
treatment   of   many   diseases   and   disorders   that   are 
currently untreatable (1-4). Presently, the utilization of 
stem cells in neural tissue repair or replacement has been 
limited. However, a continued understanding of stem cell 
biology and the pathology of neural diseases may lead to 
future clinical therapies. 
Stem cells, whether embryonic (ESC) or adult (ASC), have 
other applications, such as providing models to study 
disease/injury or in drug screening (5-8). In particular, the 
generation of neurons from stem cells affords the unique 
opportunity to study human neural processes in primary 
cells. However, customized protocols must be established 
to generate specific classes of neurotransmitter-producing 
cells. 
We have previously reported the generation of functional 
neurons   transdifferentiated   from   human   mesenchymal 
stem cells (MSCs) (9, 10). However, while our previous 
reports   investigated   the   feasibility   for   neuronal 
transdifferentiation   from   MSCs,   the   current   study 
elucidates in great detail the protocol to generate these 
cells, as well as classifies the types of neurons produced. 
Additionally,   our   laboratory   has   reported   the 
transdifferentiation of MSCs into dopamine progenitor 
cells using a separate induction protocol (11).
MSCs are mesoderm-derived cells primarily resident to 
the adult bone marrow (BM), which undergo lineage-
specific   differentiation  along   adipogenic,   chondrogenic 
and   osteogenic   paths   (12,   13).   MSCs   are   attractive 
candidates in tissue repair medicine given their relative 
ease in harvesting, isolation and expansion (14). MSCs also 
possess defined transcriptional mechanisms that may be 
responsible for their observed plasticity, since they have 
been  shown  to   generate   cells  of  both  endoderm  and 
ectoderm (15-19).
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In the present report, we investigated the neurotransmitter 
phenotype   displayed   by   the   MSC-derived   neurons 
generated from our protocol. We previously identified 
several key neurotransmitter genes upregulated in the 
neurons using a microarray-based approach (10). These 
studies formed the impetus to validate the classes of 
neurotransmitters   produced   by   these   neurons   at   the 
protein   level,   and   to   identify   whether   certain 
neurotransmitters were unique to specific subpopulations 
of neurons or homogenously expressed. We also examined 
whether   the   neurons   were   excitable   in   response   to 
exogenously   applied   neurotransmitters   through 
electrophysiological studies.
MATERIALS AND METHODS
Reagents and Antibodies
Dulbecco’s modified Eagle’s medium (DMEM) with high 
glucose, DMEM/F12, L-glutamine and B-27 supplement 
were purchased from Gibco (Carlsbad, CA). Fetal calf 
serum (FCS), all-trans retinoic acid (RA), γ-aminobutyric 
acid   (GABA),   glutamate   and   Ficoll-Hypaque   were 
purchased from Sigma (St. Louis, MO). Defined fetal calf 
serum   was   purchased   from   Atlanta   Biologicals 
(Lawrenceville, GA). Recombinant human basic fibroblast 
growth factor (bFGF) was purchased from R&D Systems 
(Minneapolis,   MN).   4′,   6-diamidino-2-phenylindole, 
dilactate (DAPI) was purchased from Molecular Probes 
(Carlsbad, CA). Recombinant human IL-1α was obtained 
from Hoffman La Roche (Nutley, NJ). 
Rabbit anti-calcitonin gene-related peptide (CGRP), -leu-
enkephalin   (Leu-Enk),   -tyrosine   hydroxylase   (TyrH), 
-glutamic   acid   decarboxylase   (GAD),   -glutamate,   goat 
anti-tryptophan hydroxylase (TrypH) and NMDA receptor 
monocolonal   antibody   (mAb)   were   purchased   from 
Chemicon (Temecula, CA), synaptic vesicle 2 (SV2) protein 
and   synaptophysin   (Syn)   mAbs   from   Novocastra 
(Newcastle, UK), rabbit anti-vasoactive intestinal peptide 
(VIP), -vesicular acetylcholine transporter (VAChT) and β-
Actin mAb from Sigma, goat anti-GABAA receptor-β1 
from Santa Cruz Biotechnology (Santa Cruz, CA) and 
rabbit anti-substance P (SP) from Biogenesis (Kingston, 
NH). FITC-goat anti-mouse was purchased from Jackson 
ImmunoResearch  (West  Grove,   PA)  and   PE-goat  anti-
rabbit   from   Open   Biosystems   (Huntsville,   AL). 
Horseradish-peroxidase   (HRP)-conjugated   anti-rabbit, 
-goat and -mouse IgG were purchased from Sigma. 
Culture of Human MSCs
MSCs were cultured from BM aspirates as described (10, 
20). The use of human BM aspirates followed a protocol 
approved   by   the   Institutional   Review   Board   of   The 
University of  Medicine  and  Dentistry  of New Jersey-
Newark campus. Unfractionated BM aspirates (2 ml) were 
diluted in 12 ml of DMEM containing 10% FCS (D10 
media)   and   then   transferred   to   vacuum-gas   plasma 
treated, tissue culture Falcon 3003 petri dishes. Plates were 
incubated, and at day 3, mononuclear cells were isolated 
by Ficoll Hypaque density gradient and then replaced in 
the culture plates. Fifty percent of media was replaced 
with   fresh   D10   media   at   weekly   intervals   until   the 
adherent cells were approximately 80% confluent. After 
four cell passages, the adherent cells were asymmetric, 
CD14–, CD29+, CD44+, CD34–, CD45–, SH2+, prolyl-4-
hydroxylase– (20).
Neuronal Induction of MSCs 
At   approximately   70-80%   confluence,   MSCs   were 
trypsinized and then subcultured in 60-mm Falcon 3002 
petri dishes or on round Fisherbrand microscope selected 
cover glass placed in 35-mm Falcon 3001 dishes (Fischer 
Scientific, Springfield, NJ). At 20% confluence, D10 media 
was replaced with neuronal induction medium (NIM), 
which comprised of Ham’s DMEM/F12, 2% FCS (Sigma), 
B27 supplement, 20 mM RA and 12.5 ng/ml bFGF. The 
media   was   unchanged   during   the   entire   period   of 
induction, maximum of 12 days.
Western Analysis and Immunoprecipitation
Whole cell extracts were prepared from D6 and D12 
induced MSCs, or uninduced MSCs (D0) as described (10). 
Briefly, cells were trypsinized, resuspended in 1x Lysis 
Buffer   (Promega,   Madison,   WI)   and   subjected   to 
freeze/thaw cycles in a dry ice/ethanol bath. Cell-free, 
whole cell lysates were obtained and total protein was 
determined   with   a   Bio-Rad   DC   protein   assay   kit 
(Hercules, CA). Whole cell extracts (20 µg) were analyzed 
by western blots using 4-20% SDS-PAGE pre-cast gels 
(Bio-Rad)   and   the   proteins   were   transferred   onto 
polyvinylidene difluoride membranes (Perkin Elmer Life 
Sciences, Boston, MA). Human brain extract (Active Motif, 
Carlsbad,   CA)   (20   µg)   served   as   positive   control   for 
neurotransmitter expression. Membranes were incubated 
overnight with primary antibodies and then detected the 
following day by 2-h incubation with HRP-conjugated 
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IgG. All primary and secondary antibodies were used at 
final dilutions of 1/1000 and 1/2000, respectively. HRP was 
developed   with   chemilluminescence   detection   reagent 
(Perkin   Elmer   Life   Sciences).   The   membranes   were 
stripped with Restore Stripping Buffer (Pierce, Rockford, 
IL) for reprobing with other antibodies. 
VIP and CGRP were immunoprecipitated from the growth 
medium (1 ml) of D0, D6 and D12 cells (approximately 104 
cells)   using   the   Catch   and   Release
®  v2.0   Reversible 
Immunoprecipitation   System   (Upstate   Cell   Signaling 
Solutions,   Charlottesville,   VA)   according   to 
manufacturer’s   specific   guidelines.   Immunoprecipitants 
(40 µl) were assayed for total protein concentration and 
then analyzed by western analysis, as described above.
Immunofluorescence
Uninduced (D0) and induced (up to D12) MSCs were 
established on glass coverslips placed in 35-mm culture 
dishes. On the day of immunofluoresence labeling, the 
cells were washed with PBS (pH 7.4) and then fixed with 
3.7%   formaldehyde   for   5   min.   This   was   followed   by 
permeabilization in 1% Triton-X. Cells were incubated 
overnight at 4°C with the following antibodies: SV2 and 
Syn mAb at final concentrations of 1/100; and rabbit anti-
CGRP, -SP, -glutamate and -GAD at final concentrations of 
1/250. Antibodies were diluted in 0.1% bovine  serum 
albumin (BSA)/PBS. Primary antibodies were developed 
with secondary FITC-goat anti-mouse and PE-goat anti-
rabbit,   at   final   concentrations   of   1/500.   Secondary 
antibodies were diluted in 0.1% BSA/PBS and incubated 
for 2 h in the dark at room temperature. For dual-labeling 
of cells for SP and GAD, rabbit anti-GAD was conjugated 
to fluorescein using the fluorescein protein labeling kit 
(Pierce).   Cells   labeled   solely   with   PE-   and   FITC-IgG 
served as isotype controls. Following labeling, cell nuclei 
were counter-stained with 300 nM DAPI diluted in 0.1% 
BSA/PBS. Cover slips were immediately transferred to 
glass   coverslides   and   examined   on   a   three-color 
fluorescent microscope (Nikon Instruments Inc., Melvelle, 
NY). Fluorescence intensities were calculated using UN-
SCAN-IT software (Silk Scientific, Orem, UT). 
Semi-quantitative RT-PCR
Total RNA (2 µg) was reverse transcribed, and 200 ng of 
cDNA was used in PCR to amplify GABAAR-β1 and 
NMDAR1. The primers for GABAAR-β1 and NMDAR1 
span   +872/+1415   (NM_000812)   and   +542/+969 
(NM_000832),   respectively.   PCR   was   done   with   the 
following primer pairs: GABAAR-β1 (forward) 5′ cct ggg 
tgt ctt ttt gga 3′ and (reverse) 5′ tcg ggg atc ttg act ttg 3′; 
and NMDAR1 (forward) 5′ cca tcc aga tgg ctc tgt 3′ and 
(reverse) 5′ ctc ttt cgc ctc cat cag 3′. PCR reactions were 
normalized by amplifying the same sample of cDNA with 
primers   specific   for   glyceraldehyde-3-phosphate 
dehydrogenase, GAPDH. The primers for GAPDH span 
+212/+809 (NM_002046), with the following sequences: 
(forward) 5’ cca ccc atg gca aat tcc atg gca 3’ and 5’ tct aga 
cgg   cag   gtc   agg   tcc   acc   3’.   The   cycling   profile   for 
GABAAR-β1 and NMDAR1 (35 cycles), and GAPDH (25 
cycles) was: 94°C for 30 sec, 55°C for 30 sec and 72°C for 30 
sec   with   a   final   extension   at   72°C   for   10   min.   PCR 
reactions (10 µl) were separated by electrophoresis on 
1.5% agarose containing ethidium bromide. Band sizes 
were   compared   with   1   kb   DNA  ladder   (Invitrogen, 
Carlsbad, CA).
FM 1-43FX Synaptic Vesicle Stain
FM 1-43FX synaptic stain was purchased from Molecular 
Probes. The procedure followed manufacturer’s suggested 
guidelines, as described previously (10). Briefly, a working 
solution of the dye was prepared at 5 µg/mL in ice cold 
PBS. D12 induced MSCs, established on glass coverslips 
placed in 35-mm culture dishes were washed with PBS. 
After this, the cells were incubated for 1 min with equal 
amounts of dye for plasma membrane labeling (1 ml). 
Cells   were   investigated   for   dye   reuptake   within 
intracellular vesicles by concurrent 1 min administration 
of 1 mM GABA or 1 mM glutamate. Excess dye was 
aspirated and the cells were fixed with ice-cold 3.7% 
formaldehyde for 10 min. Cell nuclei were counter-stained 
with 300 nM DAPI and immediately examined on a three-
color   fluorescent   microscope.   Administration   of   1% 
BSA/PBS served as a vehicle control. 
Electrophysiological Recordings 
Whole-cell configuration was used to record electrical 
activity   with   an   Axopatch   200B   amplifier   (Axon 
Instruments, Foster city, CA), via a Digidata 1322A analog-
to-digital converter (Axon Instruments), and pClamp 9.2 
software (Axon Instruments). Data were filtered at 1 kHz 
and sampled at 5 kHz. 
D12 cells were transferred to a 35-mm culture dish filled 
with a standard external solution containing: 140 mM 
NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM 
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HEPES, and 10 mM glucose (320 mOsm, pH set to 7.3 with 
Tris-base). The patch electrodes had a resistance of 3-5 
MW, when filled with pipette solution containing: 140 mM 
CsCl, 2 mM MgCl2, 4 mM EGTA, 0.4 mM CaCl2, 10 mM 
HEPES, 2 mM Mg-ATP, and 0.1 mM GTP. The pH was 
adjusted to 7.2 with Tris-base, and the osmolarity was 
adjusted to 280-300 mOsm with sucrose. Drugs (GABA, 
glutamate) were added to the superfusate applied to the 
cell using a fast perfusion system (Y-tube). Solutions in the 
vicinity of a neuron can be completely exchanged within 
40 ms without damaging the seal.
All  electrophysiological   recordings   were   performed   at 
room temperature (22-24°C).
Statistical Analysis
Statistical data analyses were performed with analysis of 
variance and Tukey-Kramer multiple comparisons test. 
p<0.05 was considered significant.
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Fig. 1: Neuropeptide expression in uninduced and induced MSCs. A. Uninduced (D0) and induced (D12) MSCs were co-labeled with PE-anti-SP 
and FITC-anti-SV2 or FITC-anti-synaptophysin (Syn), and then counterlabeled with nucleus-specific DAPI. Figure shows representative labelings of five 
different experiments. Images are shown at 10X magnification. B. Media from uninduced (D0) and induced (D6 and D12) MSCs was immunoprecipitated 
with anti-VIP and anti-CGRP and then analyzed by western blot. Representative blots are shown for three different experiments. Band densities were 
quantified and normalized to total protein. Results are presented as mean ± SD relative fold change, where the lowest value is arbitrarily assigned a value 
of 1. C. Uninduced and induced MSCs were labeled at 2 day intervals, up to 12 days, with PE-anti-CGRP and then counterlabeled with DAPI. Relative 
fluorescence intensities were normalized to values for uninduced cells, which were arbitrarily assigned a value of 1. Figure shows representative labelings 
of five different experiments. Images are shown at 10X magnification. D. Whole cell extracts from D0, D6 and D12 cells were prepared and analyzed by 
western blots with anti-Leu-Enkephalin. Normalizations were performed with anti-β-actin. Representative blots are shown for three different experiments. 
Band quantification was performed as in B  *p<0.05 vs. D12 induced cells  **p<0.05 vs. uninduced cells94
RESULTS 
Production and packaging of neuropeptides by induced 
MSCs
We have previously reported on the transdifferentiation of 
MSCs into neurons (10). However, the study only briefly 
investigated the types of neurotransmitters produced by 
the   neurons   through   microarray   analyses   (10).   This 
preliminary data demonstrated  that  MSCs  induced  to 
form neurons for 12 days (D12) upregulated genes specific 
for   peptidergic,   GABAergic   and   cholinergic   neurons 
(Table 1) (10). Additionally, we found that D12 cells were 
capable of biosynthesis and release of the neuropeptide, 
SP, upon stimulation with the pro-inflammatory cytokine, 
IL-1α (24). 
We further explored our previous findings by assessing 
the types of neurons produced by our induction protocol. 
The first set of studies examined whether SP is packaged 
into synaptic vesicles. Uninduced (D0) and induced (D12) 
MSCs were stimulated with IL-1α, then co-labeled for SP 
and synaptic vesicle 2 (SV2) protein or synaptophysin 
(Syn), and studied by immunofluorescence (Fig. 1A). D12 
cells expressed both synaptic proteins (SV2 –second row, 
first panel; Syn –fourth row, first panel), and SP (second 
and   fourth   rows,   second   panel),   with   co-localization 
throughout the cell body and neurites (Merge –second and 
fourth rows, fourth panel). Approximately 61% of D12 
cells were positive for SP expression. In contrast, SV2, Syn 
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Fig. 2: Expression of CNS neurotransmitters in uninduced and induced MSCs. A. Whole cell extracts from uninduced (D0) and induced (D6 
and D12) MSCs were prepared and analyzed by western blots with anti-tyrosine hydroxylase (TyrH), -tryptophan hydroxylase (TrypH), -glutamic acid 
decarboxylase (GAD) and -vesicular acetylcholine transporter (VAChT). Normalizations were performed with anti-β-actin. Human brain extract served as 
positive control. Representative blots are shown for three different experiments. Band densities were quantified and normalized to total protein. Results 
are presented as mean ± SD relative fold change, where the lowest value is arbitrarily assigned a value of 1. B. D12 induced cells were labeled with PE-
anti-GAD and then counter-labeled with DAPI. Figure shows representative labelings of five different experiments. Images are shown at 20X magnification. 
C. Uninduced and induced MSCs were labeled at 2 day intervals, up to 12 days, with PE-anti-glutamate and then counterlabeled with DAPI. Relative 
fluorescence intensities were normalized to values for uninduced cells, which were arbitrarily assigned a value of 1. Figure shows representative labelings 
of five different experiments. Images are shown at 10X magnification.*p<0.05 vs. uninduced cells **p<0.05 vs. D12 induced cells95
and SP levels were undetectable in D0 cells (first and third 
rows). 
Table   1:   Neurotransmitter   genes   upregulated   in   MSC-derived 
neurons.
Neurotransmitter Endogenous 
Source
Physiological 
Function
Reference
Acetycholine Central/peripheral 
nervous system
Excitatory,   skeletal 
muscle contraction, 
synaptic plasticity
(10, 21)
GABA Central   nervous 
system
Inhibitory   or 
excitatory,   brain 
development
(10, 22)
Neuropeptides Central/peripheral 
nervous system
Synaptogenesis, 
glial   morphology, 
tumorigenesis
(10, 23)
Classes   of   neurotransmitter   genes   that   have   been   shown   to   be 
upregulated in MSC-derived neurons through a microarray approach 
(10). Except for the neuropeptide, SP, validation at the protein level was 
not previously studied.
We next determined whether induced MSCs synthesize 
and/or release other neuropeptides, specifically VIP, CGRP 
and Leu-Enk (Figs. 1B-1D). Western analyses of cellular 
extracts from uninduced and induced MSCs showed low 
to undetectable levels of VIP and CGRP (data not shown). 
We therefore assayed the growth media to determine 
whether these neuropeptides were being released (Fig. 
1B). Immunoprecipitation of VIP from the media showed 
elevated   levels   in   the   uninduced   MSCs   (D0),   with   a 
gradual decrease in production during neuronal induction 
(top row, white bars). Interestingly, the opposite results 
were found for CGRP, with intracellular (Fig. 1C) and 
extracellular   (Fig.   1B,   bottow   row,   gray   bars)   levels 
increasing during induction and peaking in the D12 cells. 
These results are consistent with previous findings, which 
show synaptic co-localization of CGRP and SP (25). As 
was observed for CGRP, Leu-Enk expression was only 
detected in induced MSCs, specifically D12 cells (Fig. 1D, 
white bar). 
Production of other neurotransmitters by induced MSCs
Our   laboratory   has   recently   developed   a   separate 
neuronal induction protocol specific for the generation of 
dopaminergic   neurons   from   human   MSCs   (11).   We 
therefore   examined   whether   the   presently   described 
protocol also produces neuronal cells capable of non-
peptidergic neurotransmitter biosynthesis. To this end, 
expression of the rate-limiting enzymes in catecholamine 
(TyrH), serotonin (TrypH) and GABA (GAD) biosynthesis, 
as well as the vesicular acetylcholine transporter (VAChT), 
were examined in uninduced (D0) and induced (D6 and 
D12) MSCs (Fig. 2A). The expression of TyrH and TrypH 
was undetectable in both uninduced and induced cells 
(first and second rows) compared to human brain extract 
controls (first and second rows, far right column). In 
contrast, a light band was detectable in D12 extracts for 
GAD (third row, far right column, white bar) and D0 
extracts for VAChT (fourth row, far left column, gray bar). 
To determine the percentage of D12 cells expressing GAD, 
we performed immunofluorescence studies in uninduced 
and induced MSCs (Fig. 2B). Only a minority of D12 cells 
was found to express GAD (22 ± 3.2%), whereas GAD 
expression   was   undetectable   in   uninduced   D0   and 
induced D6 cells (data not shown). Because glutamate is 
the substrate for GAD-mediated GABA biosynthesis, we 
examined   MSCs   for   glutamate   expression   during   the 
entire course of neuronal induction (Fig. 2C). Low to 
undetectable levels of glutamate were observed in the 
induced   cells,   with   no   expression   detected   in   the 
uninduced cells (far left panel). 
In summary, a population of D12 cells was found to 
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Fig. 3: Colocalization of SP and GAD in induced MSCs. D12 cells were co-labeled with FITC-anti-GAD and PE-anti-SP, and then counter-labeled 
with DAPI. Figure shows representative labelings of five different experiments. Images are shown at 40X magnification.96
express   GAD,   whereas   the   rate-limiting   enzymes   in 
catecholamine   and   serotonin   biosynthesis,   and   the 
acetylcholine transporter, were not detected. Low to basal 
levels of glutamate were found in the induced cells, thus 
potentially limiting the availability of substrate for GABA 
biosynthesis.
Distinct populations of SP+ and GAD+ neuronal cells
The next set of studies asked whether the peptidergic 
(SP+) and putative GABAergic (GAD+) neurons existed as 
distinct   sub-populations,   or   whether   some   cells   were 
capable of producing both neurotransmitters. To address 
this question, we co-labeled D12 induced MSCs for GAD 
(green) and SP (red) expression and observed the cells by 
immunofluorescence (Fig. 3). Very few cells (<1%) were 
found to co-express SP and GAD (Merge –far right panel). 
The  results  suggest that the peptidergic and  putative 
GABAergic   cells   primarily   exist   as   two   distinct   sub-
populations.
Neurotransmitter-evoked responses in D12 induced cells
We have previously shown that D12 induced MSCs are 
capable   of   releasing   neurotransmitter   in   response   to 
membrane   depolarization   by   KCl   (10).   However,   one 
hallmark of mature neurons that we have not previously 
investigated is neurotransmitter-evoked currents. Within 
the central nervous system, the main neurotransmitters 
are glutamate and GABA, with glutamate being excitatory 
and   GABA  being  inhibitory.  We  therefore  determined 
whether the D12 induced cells could respond to glutamate 
and GABA treatment. 
The first set of studies examined the expression of the 
ionotrophic glutamate receptor, NMDA, and a subunit of 
the GABAA receptor, GABAAR-β1, in uninduced and D12 
induced cells (Fig. 4). Distinct bands were observed in D12 
cells for GABAA (top panel) and NMDA (middle panel) 
receptor mRNA (Fig. 4A) and protein (Fig. 4B), while 
bands   were   undetectable   for   uninduced   cells. 
Interestingly,   although   there   appeared   to   be   a   large 
increase in GABAAR-β1 mRNA in the D12 cells, this did 
not seem to be reflected accurately at the protein level. 
One explanation for this observation could be the large 
number   of   cycles   (35)   used   to   amplify   GABAAR-β1 
mRNA. Additionally, GABAAR-β1 may only be expressed 
on the small population of cells expressing GAD, therefore 
its levels in a whole cell preparation may be reduced.
Next, we investigated whether the D12 induced cells are 
capable   of   releasing   neurotransmitters   in   response   to 
glutamate or GABA treatment. For this experiment, D12 
cells were incubated with the membrane dye, FM1-43 FX, 
as previously reported (Fig. 5A) (10). Cells undergoing 
exocytotic vesicular release in response to treatment will 
show a pattern of punctate staining along the neurites, 
thus   indicating   vesicular   recycling   following   synaptic 
release. D12 cells treated for 1 min with GABA (left panel) 
or glutamate (middle panel) possessed cellular processes 
demonstrating   a   pattern   of   staining   consistent   with 
vesicular dye reuptake. Cells treated with vehicle control 
(BSA;   right   panel)   did   not   exhibit   a   similar   staining 
pattern. As shown previously, pre-conditioning with a 
calcium chelator such as EDTA inhibited vesicular release 
and dye reuptake (data not shown) (10). 
The final set of studies examined whether D12 induced 
cells exhibit an electrophysiological response to exogenous 
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Fig. 4: Expression of GABA and glutamate receptors in uninduced (D0) and induced (D12) MSCs. A. Total RNA from D0 and D12 cells 
was studied for expression of the GABAA  receptor β1 subunit and NMDA1 receptor by RT-PCR. Normalizations were performed with oligonucleotides 
specific for GAPDH. Representative gel is shown for three different experiments.   B. Whole cell extracts from D0 and D12 cells were prepared and 
analyzed by western blots with anti-GABAAR-β1 and anti-NMDAR1. Normalizations were performed with anti-β-actin. Representative blots are shown for 
three different experiments.97
glutamate   or   GABA   (Fig.   5B   and   5C).   For   these 
experiments, whole-cell currents were recorded from D12 
cells voltage-clamped at a holding potential of -60 mV. The 
application of either 1 mM GABA (Fig. 5B) or glutamate 
(Fig. 5C) induced inward currents. In 3 of 12 D12 induced 
cells examined, 1 mM GABA induced an inward current of 
512 ± 274pA and 1 mM glutamate of 52 ± 14 pA. GABA 
and glutamate induced no current in 10 studied cells 
induced for 8 days (data not shown). 
In summary, D12 induced MSCs express receptors for both 
glutamate and GABA (Fig. 4). These receptors appear to be 
functional, since administration of either neurotransmitter 
elicited   a   response,   as   determined   by   cellular   and 
electrophysiological approaches (Fig. 5).
DISCUSSION
In this study we report on the heterogeneous phenotype 
displayed   by   human   MSC-derived   neurons.   We   have 
previously   demonstrated   that   MSC-derived   neurons 
undergo a neurogenic program of differentiation, with 
observation of mature and functional neuronal attributes 
following 12 days induction (10). However, this study did 
not characterize the types of neurons produced by the 
induction protocol (10). The present study examined the 
neurotransmitter   phenotype   of   the   neurons,   and 
determined   their   excitability   upon   exogenous 
neurotransmitter   administration.   Interestingly,   we 
observed   two   distinct   classes   of   neurotransmitter 
producing   cells;   (1)   peptidergic   and   (2)   putative 
GABAergic neurons, a percentage of which were excitable 
in   the   presence   of  exogenously   applied   glutamate   or 
GABA. 
We have previously shown that 12-day induced MSCs 
(D12 cells) synthesize the neurotransmitter SP following 
stimulation with the pro-inflammatory cytokine, IL-1α 
(24). It could be argued that since IL-1α is necessary to 
induce   SP   production   (Fig.   1A),   perhaps   similar 
stimulation is necessary to induce the production of other 
neurotransmitters   not   found   in   the   present   study. 
However, D12 cells express mRNA for the gene encoding 
SP (TAC1) prior to IL-1α stimulation (24). Translation is 
halted   by   the   presence   of   specific   miRNAs   which 
transiently   inhibit   SP   production   (26).   This   level   of 
regulation is alleviated by stimulation with IL-1α (26). 
Since   peptidergic   and   GABAergic   transcripts   were 
principally detected in previous microarray studies, these 
neurotransmitters were investigated in greater detail (Figs. 
1 and 2) (10). 
Interestingly,   we   observed   production   of   several 
neuropeptides during the course of neuronal induction 
(Fig. 1). VIP was synthesized by uninduced cells, while 
D12 cells produced CGRP and Leu-Enk, as well as SP. 
These findings are logical, since CGRP and SP have been 
shown   to   co-localize   and   have   immunostimulatory 
functions, while VIP is generally immunosuppressive (25, 
27).  Although   immunoprecipitated   culture   media   was 
analyzed, we have reported similar results intracellularly 
(28). 
We   assessed   the   presence   of   other,   non-peptidergic, 
neurotransmitters in induced cells by examining the rate-
limiting enzymes in neurotransmitter biosynthesis (TyrH, 
TrypH,   GAD),   transport   proteins   (VAChT)   or   the 
neurotransmitter itself (glutamate) (Fig. 2). Only GAD, the 
rate-limiting   enzyme   in   GABA   biosynthesis,   was 
upregulated in the D12 cells (Fig. 2A). These findings were 
interesting, since GABA is principally found within the 
central nervous system, while MSCs are linked to the 
peripheral nervous system within the BM. Neuropeptide 
production would appear to be more characteristic of 
neurons derived from MSCs than GABA. However, GABA 
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Fig.  5:   GABA   and   glutamate   elicit   responses  in  D12   induced 
MSCs. A. FM1-43 FX lipophilic plasma membrane dye was added at 5 µg/
mL to D12 cells. Cells were cultured on glass coverslips, with dye incubation 
lasting for 1 min. Cells were fixed with ice-cold 3.7% formaldehyde and then 
examined for plasma membrane staining. Intracellular vesicle dye reuptake 
was studied by treating cells with 1 mM GABA (left panel) or 1 mM 
glutamate (middle panel) following labeling. Vehicle controls used 1% BSA 
(right panel). Figure represents four different experiments, each performed 
with cells from a different donor. Representative inward currents elicited by 
1 mM GABA (B) or 1 mM glutamate (C) from cells in culture for 12 days. The 
peak   amplitude   is   49   pA   for   GABA-induced   current,   and   81   pA   for 
glutamate-induced current. Whole-cell currents were recorded at a holding 
potential of -50 mV.98
production was not specifically measured, since accurately 
determining its levels is difficult due to instability. Further 
assessment of stored and released GABA is necessary to 
confidently demonstrate a GABAergic phenotype. 
Colocalization of SP and GABA within synaptic boutons 
has been well established within the brain, yet only a 
small percentage of D12 cells were found to co-express the 
transmitters (Fig. 3) (29, 30). These results seem to indicate 
two distinct populations of cells. However, it is entirely 
possible; given the small punctuate immunoreactivity for 
SP in these cells (Fig. 3), that this is a result of SP reuptake 
from the media and not co-localization. 
These findings suggest that two distinct sub-populations 
(peptidergic and GABAergic) of cells exist. In order to 
clearly separate the new sub-populations from parental 
cells,   it   would   be   interesting   to   examine   cell   surface 
markers such as CD14, CD29, CD44, CD34, CD45, SH2, in 
addition to SP and GAD. A difference in expression may 
indicate that some parental cells are more apt to form 
peptidergic rather than GABAerigic cells. 
Other   evidence   of   heterogeneity   is   apparent   from 
studying the excitability of the induced cells (Figs. 4 and 
5). One hallmark of the newly derived neurons should be 
excitability in response to exogenous glutamate or GABA 
administration. Although the cells were found to express 
both protein and transcript for the glutamate and GABA 
receptors  (Fig.   4),   we   recorded   GABA-  or   glutamate-
elicited currents in only 25% of the D12 cells (Fig. 5). 
Another   interesting   observation  was   that   we   did   not 
observe a GABA or glutamate response at concentrations 
of less than 1 mM. Physiologically, this dose is very high 
(although, in the synapses, the normal concentrations are > 
1mM), and indicates that the D12 cells may not be fully 
mature.
A possible explanation for the heterogeneity found within 
the D12 cells is that MSCs themselves are inherently 
heterogeneous in vitro. Our laboratory has recently shown 
that this heterogeneity increases with the number of cell 
passages (15). Heterogeneity is not something that would 
be beneficial when applying neurons derived from MSCs 
to specific diseases. Ideally, a pure population of well-
defined neurons and possibly supportive cells, such as 
glia, would seem to be best suited for neural regeneration 
or   repair.   We   have   recently   generated   an   induction 
protocol   specific   for   the   generation   of   dopaminergic 
progenitor cells from human MSCs (11). This research 
may   be   useful   in   application   towards   diseases   that 
specifically   target   the   destruction   of   dopaminergic 
neurons, such as Parkinson’s.
The   findings   of   the   present   study   are   particularly 
significant and may be useful in understanding how to 
formulate new induction protocols towards the generation 
of other specific types of neurons from human MSCs. By 
understanding the heterogeneity within MSC cultures we 
may   be   able   to   formulate   improved   methods   for 
producing   pure   neuronal   populations.   Such 
advancements could provide a supply of “off-the-shelf” 
stem cells, tailor-made to treat many different neurological 
conditions.
In summary, the present report demonstrates that our 
current   neuronal   induction   protocol   generates   a 
phenotypically   heterogenous   population   of   neurons, 
which   show   neurotransmitter-evoked   excitability   in   a 
small percentage of cells. 
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PROTOCOLS
Reagents
• DMEM with high glucose 
• Ham’s F12 media 
• L-glutamine 
• B-27 supplement 
• fetal calf serum 
• retinoic acid 
• Ficoll-Hypaque 
• bFGF 
• Falcon 3003, 3002, 3001 petri dishes 
• Fisherbrand microscope selected cover glass 
Preparation of Media
Expansion Medium
• 10% defined FCS in DMEM with high glucose and glutamate 
Differentiation Medium
• Ham’s F12 media with 2% FCS, supplemented with B27 (final concentration 1x), 20 mM RA and 12.5 ng/ml 
bFGF 
• Stock solution of RA should be diluted in DMSO to 20 mM 
Isolation and Culture of MSCs
1. Dilute unfractionated BM aspirates (2 ml) in 12 ml of DMEM containing 10% FCS (D10 media) and then 
transfer to vacuum-gas plasma treated, tissue culture Falcon 3003 petri dishes.
2. Incubate plates at 37°C.
3. At day 3, isolate mononuclear cells by Ficoll Hypaque density gradient (buffy coat layer) and then replate in 
the same cultures.
4. Replace 50% of media at weekly intervals with fresh D10 media until the adherent cells are approximately 80% 
confluent.
5. Trypsinize and subculture at a ratio of 1:3 to 1:6.
6. After 4 cell passages the adherent cells should be asymmetric, and display the following phenotype: CD14–, 
CD29+, CD44+, CD34–, CD45–, SH2+, prolyl-4-hydroxylase-.
Neuronal Induction of MSCs
1. At approximately 70-80% confluence, and between passages 3 and 10, trypsinize MSCs and then subculture in 
60-mm Falcon 3002 petri dishes or on round Fisherbrand microscope selected cover glass placed in 35-mm 
Falcon 3001 dishes. 
2. For western analysis seed 10
4 MSCs in 60-mm tissue culture dishes. For immunofluorescence, seed 10
3 MSCs in 
35-mm tissue culture dishes on glass coverslips. 
3. Allow cells to adhere to the culture surface overnight at 37°C in D10 media. 
4. At 20% confluence, replace D10 media with neuronal induction medium (see preparation of differentiation 
medium). 
5. In parallel, culture MSCs in media alone with vehicle used for reconstitution of RA and growth factors. These 
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cells shall serve as vehicle control. 
6. Leave media unchanged during the entire period of induction, maximum of 12 days. 
7. All experimental endpoints should be performed with a maximal confluence of 70% to control for contact 
inhibition. 
8. Experimental endpoints should be 6 and 12 days induction, which correspond to partially differentiated and 
fully differentiated neuronal phenotype.
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